Renstar Medical Research

What Renstar Medical Research does

Renstar Medical Research is a privately-held, multi-specialty standalone clinical research site headquartered in Ocala, Florida (operating as Renstar, LLC). The firm conducts Phase I through Phase IV clinical trials on behalf of pharmaceutical sponsors and contract research organizations across therapeutic areas including Alzheimer's disease, Parkinson's disease, migraine, COPD, diabetes, diabetic neuropathy, eczema, hidradenitis suppurativa, hypertension, hypercholesterolemia, idiopathic pulmonary fibrosis, psoriasis, osteoarthritis, and pattern hair loss. The site serves two principal counterparties: patients in North Central Florida seeking access to investigational therapies, and pharmaceutical sponsors and CROs seeking enrollment-ready trial execution with a less than 2% dropout rate.

The company's core products are end-to-end clinical trial execution, a 10-bed Phase I facility with on-site pharmacy, laboratory processing, overnight confinement capacity, and specialized equipment (ECG, refrigerated centrifuges, locked freezers), complimentary memory evaluations, and dedicated patient recruitment services. The technology stack centers on proprietary protocol-tracking software that supports regulatory document submission and internal protocol monitoring, plus a proprietary data management system that surfaces historical and current enrollment, investigator experience, study initiation timelines, and patient demographics across an in-house research database of approximately 15,000 individuals.

Renstar generates revenue through professional services fees paid by pharmaceutical sponsors and CROs under per-study contracts; clinical trial participation is provided at no cost to volunteers, with optional compensation for time and travel. Operating across four clinic locations concentrated in Ocala, the site has participated in more than 700 clinical research studies and works with 100+ sponsors and CROs including Eli Lilly, Merck, Pfizer, Novartis, Amgen, AbbVie, Janssen, Roche/Genentech, and Biogen, alongside CRO channel partners Quintiles, Parexel, PPD, ICON, inVentiv, and Inc Research. In 2025, Renstar joined PhaseWell Research, a clinical research site platform, signaling participation in ongoing site-network consolidation. Participant recruitment combines traditional media, digital/social channels, community events, physician referrals, and a paid referral program offering $55 per referred volunteer.

Name

Renstar Medical Research

Legal name

Renstar, LLC

Website

https://renstar.net

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

101–250 employees

Short description

Renstar Medical Research is a multi-specialty clinical research site in Ocala, FL conducting Phase I-IV clinical trials across multiple therapeutic areas. The firm serves pharmaceutical sponsors and CROs with proprietary data management, a roughly 15,000-volunteer research database, and a less than 2% dropout rate.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Clinical Trial Pharmacy & IMP Management at Site (HLAGACAK)

akta.pro secondary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Clinical trial services
• Phase I-IV research
• Patient recruitment
• Memory loss research
• Clinical research site

Headquarters

HQ city

Ocala

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Clinical Trial Execution Services: Renstar receives compensation from pharmaceutical companies and CROs (sponsors) for executing clinical trials. Revenue is generated through professional services fees for conducting Phase I through IV clinical research studies on behalf of sponsors.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Core offering

Renstar Medical Research is a standalone clinical research site that conducts Phase I through Phase IV trials for pharmaceutical sponsors and CROs across therapeutic areas including Alzheimer's, Parkinson's, migraine, COPD, diabetes, neuropathy, eczema, psoriasis, and high blood pressure. It also delivers free memory evaluations, operates a dedicated Phase I facility with overnight confinement capabilities, and provides patient recruitment services supported by proprietary protocol tracking and data management systems.

Product overview

Renstar Medical Research is a multi-specialty standalone clinical research site conducting Phase I through Phase IV trials. Their core offerings include clinical research trials across diverse therapeutic areas (neurology, pulmonology, endocrinology, dermatology, pain management), complemented by free memory evaluation services, a Phase I clinical trial facility with overnight confinement capabilities, and dedicated patient recruitment services using proprietary data management systems and a database of approximately 15,000 individuals.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Trials

Quantifiable outcome

• Less than 2% drop-out rate of enrolled individuals
• +3 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

28 partnerships are on record, tiered core and minor.

• PhaseWell ResearchcoreStrategic or Co-development Partner · 1 January 2025Renstar Medical Research has joined PhaseWell Research, a clinical research site company united by a shared commitment to advance the future of medicine. This represents a significant partnership/merger of clinical research site organizations.
• Eli Lilly & CominorStrategic or Co-development PartnerPharmaceutical company that has sponsored clinical trials with Renstar Medical Research
• MerckminorStrategic or Co-development PartnerPharmaceutical company that has sponsored clinical trials with Renstar Medical Research
• Roche - GenentechminorStrategic or Co-development PartnerPharmaceutical company that has sponsored clinical trials with Renstar Medical Research
• PfizerminorStrategic or Co-development PartnerPharmaceutical company that has sponsored clinical trials with Renstar Medical Research
• NovartisminorStrategic or Co-development PartnerPharmaceutical company that has sponsored clinical trials with Renstar Medical Research
• AmgenminorStrategic or Co-development PartnerPharmaceutical company that has sponsored clinical trials with Renstar Medical Research
• AbbVieminorStrategic or Co-development PartnerPharmaceutical company that has sponsored clinical trials with Renstar Medical Research
• JanssenminorStrategic or Co-development PartnerPharmaceutical company (Johnson & Johnson) that has sponsored clinical trials with Renstar Medical Research
• Biogen IdecminorStrategic or Co-development PartnerPharmaceutical company that has sponsored clinical trials with Renstar Medical Research
• QuintilesminorChannel Partner/ Reseller/ DistributorContract Research Organization (CRO) that has partnered with Renstar Medical Research for clinical trial execution
• ParexelminorChannel Partner/ Reseller/ DistributorContract Research Organization (CRO) that has partnered with Renstar Medical Research for clinical trial execution
• PPD PharmaminorChannel Partner/ Reseller/ DistributorContract Research Organization (CRO) that has partnered with Renstar Medical Research for clinical trial execution
• IconminorChannel Partner/ Reseller/ DistributorContract Research Organization (CRO) that has partnered with Renstar Medical Research for clinical trial execution
• Inc ResearchminorChannel Partner/ Reseller/ DistributorContract Research Organization (CRO) that has partnered with Renstar Medical Research for clinical trial execution
• InVentiv HealthminorChannel Partner/ Reseller/ DistributorContract Research Organization (CRO) that has partnered with Renstar Medical Research for clinical trial execution
• AllerganminorStrategic or Co-development PartnerPharmaceutical company that has sponsored clinical trials with Renstar Medical Research
• ForestminorStrategic or Co-development PartnerPharmaceutical company (now part of Actavis/Allergan) that has sponsored clinical trials with Renstar Medical Research
• EisaiminorStrategic or Co-development PartnerPharmaceutical company that has sponsored clinical trials with Renstar Medical Research
• CelgeneminorStrategic or Co-development PartnerPharmaceutical company (now part of Bristol-Myers Squibb) that has sponsored clinical trials with Renstar Medical Research
• Daiichi SankyominorStrategic or Co-development PartnerPharmaceutical company that has sponsored clinical trials with Renstar Medical Research
• TevaminorStrategic or Co-development PartnerPharmaceutical company that has sponsored clinical trials with Renstar Medical Research
• TonixminorStrategic or Co-development PartnerPharmaceutical company that has sponsored clinical trials with Renstar Medical Research
• SymbiominorStrategic or Co-development PartnerPharmaceutical company that has sponsored clinical trials with Renstar Medical Research
• BDSIminorStrategic or Co-development PartnerPharmaceutical company that has sponsored clinical trials with Renstar Medical Research
• Local Area Hospitals (AdventHealth Ocala, HCA Florida Ocala)minorStrategic or Co-development PartnerTwo local hospitals located within 5 minutes of the Phase I facility and within 2 miles of each other
• Local Imaging FacilityminorStrategic or Co-development PartnerLong-standing professional relationship with local imaging facility providing X-ray, MRI, PET, digital mammography, ultrasound, bone densitometry, multi-slice CT, and fluoroscopy services with trained technologists
• Accredited Sleep LaboratoriesminorStrategic or Co-development PartnerTwo local accredited sleep laboratories overseen by board certified physicians in sleep medicine with certified, trained technologists

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• ICON plc: Global CRO and clinical research services provider with site and decentralized trial capabilities. Broad incumbent with overlapping Phase I–IV clinical trial services addressed to the same pharma and biotech sponsors as Renstar.
• IQVIA: World's largest CRO with embedded clinical research site operations and a global site network. Broad incumbent whose clinical trial delivery services overlap with Renstar's Phase I–IV offering from a much larger portfolio.
• Syneos Health: Large global clinical research services organization providing Phase I–IV clinical solutions and site management alongside broader CRO offerings. Broad incumbent whose clinical site and trial services compete for similar sponsor relationships as Renstar.

Direct peers

• Benchmark Research: Multi-therapeutic clinical research site organization conducting Phase II–IV trials for pharma sponsors. Comparable to Renstar as an independent research site targeting similar therapeutic indications and sponsor mix.
• Elligo Health Research: Tech-enabled clinical research site network offering decentralized and traditional site services to biopharma sponsors. Comparable to Renstar as a competing clinical research site serving the same Phase I–IV sponsor customer base.
• Velocity Clinical Research: Large integrated site network executing Phase I–IV trials across multiple therapeutic areas for biopharma sponsors and CROs. Direct peer as a competing multi-site clinical research organization with similar sponsor base and delivery model.
• Accellacare: Site Management Organization operating multi-specialty clinical research sites across the U.S. Comparable to Renstar as a site-network SMO serving sponsor and CRO clients across diverse therapeutic areas.
• PhaseWell Research: Strategic parent SMO network uniting multi-specialty clinical research sites including Renstar. Operates the same Phase I–IV site services business model under a consolidated contracting and feasibility infrastructure, making it the closest direct peer.
• DM Clinical Research: Independent multi-specialty clinical research site network conducting Phase I–IV trials across multiple therapeutic areas. Directly comparable site-services competitor with similar sponsor and CRO customer base.
• Meridian Clinical Research: Independent multi-specialty clinical research site network running Phase I–IV trials across therapeutic areas including neurology, endocrinology, and dermatology. Directly comparable in offering, sponsor relationships, and site-based delivery model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/renstar-medical-research

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Renstar Medical Research